H umans have coevolved with malaria parasites of the genus Plasmodium for millennia (1) . Plasmodia invade red blood cells (RBCs) and feed on hemoglobin, and thus, malaria infection profoundly disrupts iron homeostasis, as erythroblasts consume 90% of the daily available iron to produce RBCs. Paradoxically, malaria parasites cannot acquire iron from intact heme (2) (3) (4) (5) , leaving iron released by hemoglobin autoxidation as the most likely iron source for plasmodia (6) (7) (8) . Furthermore, for unknown reasons, iron supplementation exacerbates the severity of malarial infections (3, (9) (10) (11) . However, mechanistic understanding of iron homeostasis in RBCs is surprisingly incomplete because most iron homeostasis proteins are absent in mature RBCs (12, 13) .
Ferroportin (FPN) is the only known iron exporter in mammalian cells; it transports iron from enterocytes, hepatocytes, and splenic macrophages into the blood to optimize systemic iron homeostasis (14, 15) . FPN expression is regulated in nucleated cells at the translational level by iron regulatory proteins and also posttranslationally by hepcidin, a systemic iron regulatory hormone, to optimize plasma iron homeostasis (16, 17) . Recently, we found that FPN was highly expressed in erythroblasts (18, 19) . Thus, we hypothesized that FPN is probably present in mature RBCs to export iron generated by hemoglobin autoxidation and thereby protect against iron accumulation, as well as malaria infection.
Confirming our hypothesis, immunoblots with different FPN antibodies detected a strong signal in both mouse and human RBCs, indicating that FPN was present in mature RBCs (Fig. 1A) (Fig. 1B) . In purified cells, the intensity of the FPN signal from RBCs was about 40% of that from erythroblasts, whereas other iron-regulatory proteins, including transferrin receptor 1, divalent metal transporter 1, and iron regulatory protein 1, were not detected in RBCs (Fig. 1C and fig. S2 ). We further evaluated FPN abundance in a massspectrum database of human RBC membranes, which included healthy controls and DiamondBlackfan anemia (DBA) patients (Table 1 and  table S1 ) (21) , and estimated that FPN occurred at 54,000 copies per cell, an amount greater than that of the integral RBC membrane protein component glycophorin C. Significances for (F) to (H) were determined by two-way ANOVA and Sidak's multiple comparisons test; significances for (I) and (K) were determined by Welch's t test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
decreased in RBCs, as hepcidin expression increased (Fig. 1E, fig. S3A ). Exogenous hepcidin treatment decreased FPN levels in erythroblasts (Fig. 1F) , in which the degradation apparatus is intact, but not in RBCs (Fig. 1G) , which lack the proteasomal degradation pathway for hepcidin. Together with findings in DBA patients (22) ( Table 1 and table  S1 ) and sickle cell disease patients (23) (fig. S3 , B and C), we observed that RBC FPN levels inversely correlated with hepcidin expression, likely owing to the regulation of FPN in erythroblasts (Fig. 1F) . Hepcidin inhibited FPN iron-export activity ( Fig. 1D ) but did not change FPN abundance on RBCs (Fig. 1G ), indicating that hepcidin binding sterically suppressed the iron-export activity of FPN (24, 25) . Fpn knockout increased non-heme iron content and intracellular ferritin levels of erythroblasts (fig. S1, E and F) and resulted in a mild compensated anemia and extramedullary erythropoiesis (figs. S4 to S6 and table S2). The anemia was not caused by a defect of erythroblast differentiation ( fig. S7 ) but instead by the increased fragility and hemolysis of the mature RBCs, as evidenced by the 2.5-fold increase of free plasma hemoglobin after storage at 4°C for 20 hours (Fig. 2, A and B, and fig. S8A ). Consistently, we found that the labile iron pool of Fpn KO RBCs increased by 80% (Fig. 2C) , and non-heme iron and ferritin levels ( Fig. 2D and  fig. S8B ) also significantly increased. Iron overload increased reactive oxygen species production by 30% (Fig. 2, E and F) , which damaged RBC plasma membranes, as shown by increased annexin V staining ( fig. S8C ) and osmotic fragility (Fig. 2G) . Consequently, the RBC half-life was reduced from 25 days in WT mice to 14 days in Fpn KO mice (Fig. 2H) . The shorter life span was attributable to a cell-autonomous defect of Fpn KO RBCs, because only 80% of Fpn KO RBCs remained in the circulation relative to WT RBCs when their survival was compared in the same animal (Fig. 2I and fig. S9 ) and the few remaining WT RBCs in the conditional KO mice increased in proportion during the RBC aging process (Fig. 2J and fig. S10 ). Consistently, serum haptoglobin depletion (Fig. 2K and fig. S11A ), increased CD163 and heme oxygenase 1 expression (figs. S11, B and C, and S5F), and iron overload observed in splenic macrophages, Kupffer cells, and renal proximal tubules ( fig. S11D ) indicated that Fpn KO mice were suffering from hemolytic anemia. These results showed that FPN was critical for exporting free iron to maintain the integrity of mature RBCs.
The high abundance of FPN on RBCs, its effects on RBC iron status, and its down-regulation by iron supplementation could therefore influence the growth of malaria parasites (3-5, 9, 10, 26) . To test this hypothesis, we intravenously injected WT and Fpn KO mice with Plasmodium yoelii YM, a lethal murine malaria strain. Fpn KO mice had 60% more parasite-infected RBCs than WT mice on multiple successive days after infection (Fig. 3A) , and they died more rapidly after infection (Fig. 3B) . We next infected multiple mice with P. chabaudi chabaudi AS, a murine strain that almost exclusively infects mature RBCs (fig. S12) . Consistently, the parasitemia of Fpn KO mice was higher than that of WT mice from days 3 to 6, before reticulocyte numbers increased and mature RBCs declined (Fig. 3C and fig. S12 ).
Because malaria has long driven the evolution of the human genome (1), we hypothesized that mutations that increased FPN levels would protect humans from malaria infection and be evolutionarily enriched in malaria-endemic regions. The FPN Q248H (glutamine to histidine at position 248) mutation occurs in sub-Saharan African populations with a heterozygote prevalence of 2.2 to 20%, depending on location (27) (28) (29) . The mutation renders FPN resistant to hepcidin-induced degradation (30) , and carriers have lower hemoglobin concentrations than controls (29) , consistent with our hypothesis that high FPN levels in erythroblasts export iron and diminish hemoglobin production (18, 19) . After screening 27 African Americans, we found three Q248H heterozygotes. Immunoblot analyses confirmed that FPN levels were increased in the RBCs of Q248H heterozygotes relative to control donors ( fig. S13 ), indicating that the mutation could have as yet unknown health consequences in carriers of African descent.
We then analyzed the parasitemia of 66 hospitalized Zambian children with uncomplicated P. falciparum malaria who were <6 years of age (Table 2 and table S3) (31, 32) . The Q248H mutation was observed in 19.7% of the children (12 heterozygotes, 1 homozygote). Compared to patients with a WT allele, who had a median Data are presented as mean ± 95% CI. Statistical significances determined for (A) and (C) with the Holm-Sidak multiple comparisons test with a = 0.05. Survival curves were analyzed with the log-rank test and Gehan-Breslow-Wilcoxon test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
of 189,667 parasites/ml, Q248H patients had 28,000 parasites/ml (two-sided Fisher's test and chi-square test, P = 0.025). Q248H patients also experienced less fulminant malaria, as manifested by tolerance of longer fever times before presentation to the hospital (median of 69 versus 37 hours, Q248H versus WT, P = 0.1). Additionally, the hemoglobin concentrations of Q248H patients were lower than those of patients with a WT allele (median of 8.8 versus 10.1 g/dl, Q248H versus WT, P = 0.1), which was consistent with the possibility that increased FPN abundance in Q248H carriers reduced the amount of iron available for hemoglobin synthesis (29, 30) . We next investigated the effects of the Q248H mutation on malarial infection in 290 primiparous Ghanaian women (Table 3 and table S4 ). Primiparae are particularly prone to placental malaria, because acquired immunity against parasites adhering to the placental syncytiotrophoblast is insufficiently developed in the first pregnancy (33) . Of 290 women, 8.6% were Q248H carriers (24 heterozygotes, 1 homozygote). Present or past placental P. falciparum infection occurred less frequently in Q248H carriers (44.0%) than in women with the respective WT allele (70.2%, P = 0.007), even after adjusting by logistic regression for known predictors of placental malaria (34) . The apparent protection that the Q248H mutation conferred against malaria infection was also seen in the analysis of peripheral blood samples (44.0 versus 60.4%, P = 0.11), even though analysis of peripheral blood is relatively insensitive for diagnosing malaria in pregnant women.
We found that the iron exporter FPN was highly abundant on mature RBCs. FPN prevents erythrocytic iron accumulation and concomitant oxidative stress and protects RBCs against malarial infection ( fig. S14 ). FPN on mature RBCs was abundant under conditions of iron deficiency but diminished with iron supplementation. Its activity was inhibited by hepcidin, which would increase the labile iron pool within RBCs and promote the growth of plasmodial parasites. These findings help to explain why iron deficiency protects against malarial infection, why iron supplementation promotes malariarelated hospitalization and mortality, and why the Q248H mutation may have undergone positive selection in African populations of malariaendemic regions, among other protective mutations (9, 10, 35). 
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